Display options
Share it on

Iran Red Crescent Med J. 2013 Jul;15(7):547-53. doi: 10.5812/ircmj.11847. Epub 2013 Jul 05.

Demographic and histological predictors of survival in patients with gastric and esophageal carcinoma.

Iranian Red Crescent medical journal

Yousef Veisani, Ali Delpisheh, Kourosh Sayehmiri, Ezzatollah Rahimi

Affiliations

  1. Students' Research Committee, Ilam University of Medical Sciences, Ilam, IR Iran ; Department of Clinical Epidemiology, Ilam University of Medical Sciences, Ilam, IR Iran.
  2. Department of Clinical Epidemiology, Ilam University of Medical Sciences, Ilam, IR Iran ; Prevention of Psychosocial Injuries Department, Research Centre, Ilam, IR Iran.
  3. Prevention of Psychosocial Injuries Department, Research Centre, Ilam, IR Iran.
  4. Liver and Digestive Research Centre, Kurdistan University of Medical Sciences, Sanandaj, IR Iran.

PMID: 24396572 PMCID: PMC3871740 DOI: 10.5812/ircmj.11847

Abstract

BACKGROUND: Little is known about the possible influence of demographic and histological risk factors on the survival of patients with esophageal and gastric cancer.

OBJECTIVES: Based on the available registry and follow-up information, this study compares 1-5 year survival rate of gastric and esophageal cancer.

PATIENTS AND METHODS: Through a concurrent (prospective) cohort study, all 366 patients with definite diagnosis of esophageal and gastric cancer who had been hospitalized at the Towhid Hospital, Sanandaj city, Kurdistan province, western Iran during a five-year period from 2006 onwards were recruited. The survival time of patients stratified by this grouping method were analyzed by Kaplan-Meier analysis and Cox regression.

RESULTS: Amongst the 366 patients, 23 had esophageal adenocarcinoma, 94 esophageal squamous-cell carcinoma and 239 had gastric adenocarcinoma. Age at diagnosis (P = < 0.001), tumor grade (P = 0.008) and practice treatment (P = < 0.001) had significant associations with the variation of survival rates in patients with esophageal but not with gastric cancer. The five-year survival rates (by year) for esophageal cancer were 49%, 27%, 24%, 22% and 19%, respectively and for gastric cancer were 41%, 17%, 13%, 10% and 5.4%, respectively.

CONCLUSIONS: Major differences between these cancers were seen in the survival rates of patients and their incidence classified by sex. Age at diagnosis and histological types were prognostic factors for survival of patients with esophageal cancer but this wasn't the case for gastric cancer.

Keywords: Demographic Factor; Esophageal Cancer; Gastric Cancer; Histological Factor; Survival

References

  1. Asian Pac J Cancer Prev. 2011;12(9):2359-63 - PubMed
  2. BMC Gastroenterol. 2011 Jan 07;11:1 - PubMed
  3. Can J Gastroenterol. 2008 Feb;22(2):143-8 - PubMed
  4. Arch Iran Med. 2008 Jul;11(4):364-70 - PubMed
  5. BMC Cancer. 2012 Jan 12;12:11 - PubMed
  6. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  7. Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5 - PubMed
  8. Cancer. 2010 Jun 15;116(12):2960-6 - PubMed
  9. Ann Thorac Surg. 2006 Sep;82(3):1073-7 - PubMed
  10. Eur J Cardiothorac Surg. 2007 Feb;31(2):154-60 - PubMed
  11. Br J Cancer. 2001 Nov 30;85(11):1671-4 - PubMed
  12. Curr Oncol. 2012 Dec;19(6):302-7 - PubMed
  13. Dis Esophagus. 2003;16(2):60-5 - PubMed
  14. World J Gastroenterol. 2011 Nov 14;17(42):4660-74 - PubMed
  15. Semin Radiat Oncol. 2007 Jan;17(1):2-9 - PubMed
  16. Br J Surg. 2012 Dec;99(12):1693-700 - PubMed
  17. Ann Surg. 2001 Sep;234(3):360-7; discussion 368-9 - PubMed
  18. Eur J Cancer. 2012 Jul;48(11):1624-32 - PubMed
  19. Singapore Med J. 2012 May;53(5):336-43 - PubMed
  20. World J Gastroenterol. 2008 May 28;14(20):3165-73 - PubMed
  21. Eur J Cancer. 1998 Dec;34(14 Spec No):2271-8 - PubMed
  22. Arch Intern Med. 2010 Jan 25;170(2):203-7 - PubMed
  23. J Thorac Oncol. 2012 Feb;7(2):443-7 - PubMed
  24. Arch Iran Med. 2007 Jan;10(1):32-7 - PubMed

Publication Types